Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

After hours: October 22 at 6:18 PM EDT ...

Something went wrong. Try again, or contact support if the problem persists. Your details are incorrect, or aren't in our system yet. Please try again, or sign up if you're new here.

Partnering with Flex enables you to answer critical questions such as: Where is the best place to manufacture your products? Which technologies will give you a competitive edge? And thanks to our know ...